☰

Guoying Tai, Ph.D. - Publications

Affiliations: 
2006 University of Washington, Seattle, Seattle, WA 
Area:
Pharmacy
Tree Info Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Mosher CM, Tai G, Rettie AE. CYP2C9 amino acid residues influencing phenytoin turnover and metabolite regio- and stereochemistry. The Journal of Pharmacology and Experimental Therapeutics. 329: 938-44. PMID 19258521 DOI: 10.1124/Jpet.109.150706  0.557
2008 Tai G, Dickmann LJ, Matovic N, DeVoss JJ, Gillam EM, Rettie AE. Re-engineering of CYP2C9 to probe acid-base substrate selectivity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1992-7. PMID 18606741 DOI: 10.1124/Dmd.108.022186  0.622
2006 Rettie AE, Tai G. The pharmocogenomics of warfarin: closing in on personalized medicine. Molecular Interventions. 6: 223-7. PMID 16960144 DOI: 10.1124/Mi.6.4.8  0.524
2005 Tai G, Farin F, Rieder MJ, Dreisbach AW, Veenstra DL, Verlinde CL, Rettie AE. In-vitro and in-vivo effects of the CYP2C9*11 polymorphism on warfarin metabolism and dose. Pharmacogenetics and Genomics. 15: 475-81. PMID 15970795 DOI: 10.1097/01.Fpc.0000162005.80857.98  0.561
2003 Rettie AE, Tai G, Veenstra DL, Farin FM, Srinouanprachan S, Lin YS, Thummel KE, Hines RN. CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians. Blood. 101: 2896-7. PMID 12642346 DOI: 10.1182/Blood-2002-11-3452  0.492
Show low-probability matches.